Title |
Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action
|
---|---|
Published in |
Psychopharmacology, August 2013
|
DOI | 10.1007/s00213-013-3214-6 |
Pubmed ID | |
Authors |
R. Christopher Pierce, Fair M. Vassoler |
Abstract |
Deep brain stimulation (DBS) has achieved substantial success as a treatment for movement disorders such as Parkinson's disease. The therapeutic efficacy and relative lack of serious side effects resulted in the expansion of DBS into the treatment of many other diseases, including obsessive-compulsive disorder, Tourette's, and depression, among others. More recently, a limited number of basic and clinical studies indicated that DBS may also be useful in the treatment of various addictions. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 25% |
United Kingdom | 4 | 20% |
Australia | 1 | 5% |
Unknown | 10 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 65% |
Scientists | 7 | 35% |
Mendeley readers
The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | <1% |
China | 1 | <1% |
Unknown | 119 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 24 | 20% |
Researcher | 21 | 17% |
Student > Bachelor | 19 | 16% |
Student > Master | 13 | 11% |
Student > Doctoral Student | 10 | 8% |
Other | 16 | 13% |
Unknown | 18 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 23% |
Neuroscience | 21 | 17% |
Psychology | 19 | 16% |
Agricultural and Biological Sciences | 13 | 11% |
Biochemistry, Genetics and Molecular Biology | 3 | 2% |
Other | 8 | 7% |
Unknown | 29 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2015.
All research outputs
#2,619,201
of 24,284,650 outputs
Outputs from Psychopharmacology
#639
of 5,523 outputs
Outputs of similar age
#22,397
of 202,890 outputs
Outputs of similar age from Psychopharmacology
#9
of 49 outputs
Altmetric has tracked 24,284,650 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,523 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,890 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.